期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
胃癌分子标靶治疗药物的新进展 被引量:2
1
作者 叶坤辉 郑安理 《临床肿瘤学杂志》 CAS 2007年第1期1-10,共10页
关键词 胃癌 分子标靶治疗 研究进展
下载PDF
进展期胃癌内科治疗研究新进展 被引量:3
2
作者 周文杰 蒋敬庭 吴昌平 《医学综述》 2008年第23期3605-3611,共7页
胃癌目前是全球第二大癌症死因,总生存率仅为15%~20%。手术是可切除胃癌的根治性治疗的重要手段之一,对于进展期胃癌,即使在胃癌根治术中采用更广泛的淋巴结清扫术也不能改善患者的生存率,多数患者最终死于复发转移。荟萃分析表明辅助... 胃癌目前是全球第二大癌症死因,总生存率仅为15%~20%。手术是可切除胃癌的根治性治疗的重要手段之一,对于进展期胃癌,即使在胃癌根治术中采用更广泛的淋巴结清扫术也不能改善患者的生存率,多数患者最终死于复发转移。荟萃分析表明辅助放、化疗可提高进展期胃癌的生存率,晚期胃癌姑息化疗可使中位生存期提高到7.5~12个月,含拓扑异构酶Ⅰ抑制剂、伊立替康、紫杉类的化疗方案能进一步提高化疗的有效率,同时新的分子靶向药物治疗将为胃癌综合治疗开辟了新的途径。 展开更多
关键词 胃癌 辅助化疗 分子标靶治疗 进展
下载PDF
Molecular targets in the treatment of alcoholic hepatitis 被引量:9
3
作者 Ashwin D Dhanda Richard WL Lee +1 位作者 Peter L Collins C Anne McCune 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第39期5504-5513,共10页
Alcohol related costs to health and society are high. One of the most serious complications of alcohol misuse to the individual is the development of alcoholic hepatitis (AH), a clinical syndrome of jaundice and progr... Alcohol related costs to health and society are high. One of the most serious complications of alcohol misuse to the individual is the development of alcoholic hepatitis (AH), a clinical syndrome of jaundice and progressive inflammatory liver injury in patients with a history of recent heavy alcohol use. It has a poor outcome and few existing successful therapies. The use of glucocorticoids in patients with severe AH is still controversial and there remains a group of patients with glucocorticoid-resistant disease. However, as our understanding of the pathogenesis of the condition improves there are opportunities to develop new targeted therapies with specific actions to control liver inflammation without having a detrimental effect on the immune system as a whole. In this article we review the molecular mechanisms of AH concentrating on the activation of the innate and adaptive immune response. We consider existing treatments including glucocorticoids, anti-tumor necrosis factor therapy and pentoxifylline and their limitations. Using our knowledge of the disease pathogenesis we discuss possible novel therapeutic approaches. New targets include pro-inflammatory cytokines such as interleukin (IL)-17, chemokines and their receptors (for example IL-8, CXCL9 and CXCR3) and augmentation of anti-inflam- matory molecules such as IL-10 and IL-22. And there is also future potential to consider combination therapy to selectively modulate the immune response and gain control of disease. 展开更多
关键词 Alcoholic hepatitis Tumour necrosis factor-m PENTOXIFYLLINE INTERLEUKINS Chemokine receptors
下载PDF
DNA G-quadruplex and its potential as anticancer drug target 被引量:3
4
作者 ONEL Buket LIN Clement YANG Dan Zhou 《Science China Chemistry》 SCIE EI CAS 2014年第12期1605-1614,共10页
G-quadruplex secondary structures are four-stranded globular nucleic acid structures form in the specific DNA and RNA G-rich sequences with biological significance such as human telomeres,oncogene-promoter regions,rep... G-quadruplex secondary structures are four-stranded globular nucleic acid structures form in the specific DNA and RNA G-rich sequences with biological significance such as human telomeres,oncogene-promoter regions,replication initiation sites,and 5′and 3′-untranslated(UTR)regions.The non-canonical G-quadruplex secondary structures can readily form under physiologically relevant ionic conditions and are considered to be new molecular target for cancer therapeutics.This review discusses the essential progress in our lab related to the structures and functions of biologically relevant DNA G-quadruplexes in human gene promoters and telomeres,and the opportunities presented for the development of G-quadruplex-targeted smallmolecule drugs. 展开更多
关键词 DNA G-quadruplexes oncogene promoters human telomeres G-quadruplex-targeted small molecules anticancer drug target
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部